Overcoming CEP85L-ROS1, MKRN1-BRAF and MET amplification as rare, acquired resistance mutations to Osimertinib

Lung cancer is the most common cancer-related cause of death worldwide, most of which are non-small cell lung cancers (NSCLC). Epidermal growth factor receptor (EGFR) mutations are common drivers of NSCLC. Treatment plans for NSCLC, specifically adenocarcinomas, rely heavily on the presence or absen...

Descripción completa

Detalles Bibliográficos
Autores principales: Kian, Waleed, Krayim, Bilal, Alsana, Hadel, Giles, Betsy, Purim, Ofer, Alguayn, Wafeek, Alguayn, Farouq, Peled, Nir, Roisman, Laila C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009227/
https://www.ncbi.nlm.nih.gov/pubmed/36923435
http://dx.doi.org/10.3389/fonc.2023.1124949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009227/
https://www.ncbi.nlm.nih.gov/pubmed/36923435
http://dx.doi.org/10.3389/fonc.2023.1124949

Ejemplares similares